Use of Tranexamic Acid in Reduction of Post-Op Complications in Mohs Micrographic Surgery
Local Injection of Tranexamic Acid May Reduce Bleeding, Injection Pain, and Other Post-op Complications During Mohs Micrographic Surgery
Sponsor: Riley McLean
Terminated
Drug supply issues
Listed as NCT04630886, this EARLY_PHASE1 trial focuses on Skin Neoplasms and remains terminated or withdrawn. Sponsored by Riley McLean, it has been updated 9 times since 2021, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
9 versions recorded-
Dec 2024 — Present [monthly]
Terminated EARLY_PHASE1
Status: Enrolling By Invitation → Terminated
-
Sep 2024 — Dec 2024 [monthly]
Enrolling By Invitation EARLY_PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Enrolling By Invitation EARLY_PHASE1
-
Jul 2023 — Jul 2024 [monthly]
Enrolling By Invitation EARLY_PHASE1
-
May 2022 — Jul 2023 [monthly]
Enrolling By Invitation EARLY_PHASE1
Status: Not Yet Recruiting → Enrolling By Invitation
▶ Show 4 earlier versions
-
May 2021 — May 2022 [monthly]
Not Yet Recruiting EARLY_PHASE1
-
Mar 2021 — May 2021 [monthly]
Not Yet Recruiting EARLY_PHASE1
-
Jan 2021 — Mar 2021 [monthly]
Not Yet Recruiting EARLY_PHASE1
-
Dec 2020 — Jan 2021 [monthly]
Not Yet Recruiting EARLY_PHASE1
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Riley McLean
For direct contact, visit the study record on ClinicalTrials.gov .